A double-blind clinical trial of fenticonazole (2%) spray versus naftifine (1%) spray in patients with cutaneous mycoses

References

• Athow-Frost T. A. M., Freeman K., Mann T. A. N., Marks R., Vollum D., Warin A. P. Clinical evaluation of fenticonazole cream in cutaneous fungal infections: a comparison with miconazole ceam. Curr. Med. Res. Opin. 1986; 10: 107, 1161. Athow-Frost T. A. M., Freeman K., Mann T. A. N., Marks R., Vollum D., Warin A. P. Clinical evaluation of fenticonazole cream in cutaneous fungal infections: a comparison with miconazole ceam. Curr. Med. Res. Opin. 1986; 10: 107, 116
   PubMed Web of Science ®Google Scholar
• Costa A. L. In vitro antimycotic activity of fenticonazole (REC 15–1476). Mykosen 1982; 25: 472. Costa A. L. In vitro antimycotic activity of fenticonazole (REC 15–1476). Mykosen 1982; 25: 47
   PubMedGoogle Scholar
• Finzi A., Fioroni A., Monici Preti P., Molinari M. A double-blind evaluation of fenticonazole cream 2% and clotrimazole cream 1% in dermatomycoses. Mykosen 1986; 29: 4143. Finzi A., Fioroni A., Monici Preti P., Molinari M. A double-blind evaluation of fenticonazole cream 2% and clotrimazole cream 1% in dermatomycoses. Mykosen 1986; 29: 414
   Google Scholar
• Jung E. G., Bisco A., Azzollini E., Sartani A., Ruffmann R. Fenticonazole cream once daily in dermatomycosis, a double-blind controlled trial versus bifonazole. Dermatologica 1988; 177: 104, 1084. Jung E. G., Bisco A., Azzollini E., Sartani A., Ruffmann R. Fenticonazole cream once daily in dermatomycosis, a double-blind controlled trial versus bifonazole. Dermatologica 1988; 177: 104, 108
   PubMedGoogle Scholar
• Kerridge D. Antifungal drugs. Drugs Today 1988; 24: 705, 7155. Kerridge D. Antifungal drugs. Drugs Today 1988; 24: 705, 715
   Google Scholar
• Kokoschka E. M., Niebauer G., Molinari M., Monici Preti P. Treatment of dermatomycoses with topical fenticonazole and econazole. Mykosen 1986; 29: 45, 506. Kokoschka E. M., Niebauer G., Molinari M., Monici Preti P. Treatment of dermatomycoses with topical fenticonazole and econazole. Mykosen 1986; 29: 45, 50
   PubMedGoogle Scholar
• Nardi D., Cappelletti R., Catto A., Leonardi A., Tajana A., Veronese M. New alpha-aryl-beta, N-imidazolylethyl benzyl and naphthylmethyl ethers with antimycotic and antibacterial activity. Arzneim. Forsch. 1981; 31: 21237. Nardi D., Cappelletti R., Catto A., Leonardi A., Tajana A., Veronese M. New alpha-aryl-beta, N-imidazolylethyl benzyl and naphthylmethyl ethers with antimycotic and antibacterial activity. Arzneim. Forsch. 1981; 31: 2123
   PubMed Web of Science ®Google Scholar
• Ryder N. S. Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Ann. N. Y. Acad. Sci. 1988; 544: 208, 2208. Ryder N. S. Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Ann. N. Y. Acad. Sci. 1988; 544: 208, 220
   PubMedGoogle Scholar
• Ryley J. E, Wilson R. G., Gravestock M. B., Poyser J. P. Experimental approaches to antifungal chemotherapy. Adv. Pharmacol. Chemother. 1981; 18: 49, 1769. Ryley J. E, Wilson R. G., Gravestock M. B., Poyser J. P. Experimental approaches to antifungal chemotherapy. Adv. Pharmacol. Chemother. 1981; 18: 49, 176
   PubMedGoogle Scholar
• Sartani A., Cordaro C. I., Panconesi E. A multicenter trial with a new imidazole derivative, fenticonazole, in superficial fungal skin infections. Curr. Ther. Res. 1988; 43: 1194, 120310. Sartani A., Cordaro C. I., Panconesi E. A multicenter trial with a new imidazole derivative, fenticonazole, in superficial fungal skin infections. Curr. Ther. Res. 1988; 43: 1194, 1203
   Web of Science ®Google Scholar
• Tajana R., Cappelletti R., Leonardi A., Nardi D., Veronese M. Synthesis and antimycotic activity of alpha-aryl-beta, N-imidazolyl-alkyl benzyl ethers. Arzneim. Forsch. 1981; 31: 212111. Tajana R., Cappelletti R., Leonardi A., Nardi D., Veronese M. Synthesis and antimycotic activity of alpha-aryl-beta, N-imidazolyl-alkyl benzyl ethers. Arzneim. Forsch. 1981; 31: 2121
   PubMed Web of Science ®Google Scholar
• Veronese M., Barzaghi D., Bertoncini A. Antifungal activity of fenticonazole in experimental dermatomycosis and candidiasis. Arzneim. Forsch. 1981; 31: 213712. Veronese M., Barzaghi D., Bertoncini A. Antifungal activity of fenticonazole in experimental dermatomycosis and candidiasis. Arzneim. Forsch. 1981; 31: 2137
   PubMed Web of Science ®Google Scholar
• Veronese M., Barzaghi D., Bertoncini A., Cornelli U. Fenticonazole: a new antifungal imidazole derivative. In vitro and in vivo antimycotic activity. Mykosen 1984; 27: 19213. Veronese M., Barzaghi D., Bertoncini A., Cornelli U. Fenticonazole: a new antifungal imidazole derivative. In vitro and in vivo antimycotic activity. Mykosen 1984; 27: 192
   Google Scholar
• Veronese M., Salvaterre M., Barzaghi D. Fenticonazole, a new imidazole derivative with antibacterial and antifungal activity: ‘in vitro’ study. Arzneim. Forsch. 1981; 31: 213314. Veronese M., Salvaterre M., Barzaghi D. Fenticonazole, a new imidazole derivative with antibacterial and antifungal activity: ‘in vitro’ study. Arzneim. Forsch. 1981; 31: 2133
   PubMed Web of Science ®Google Scholar
• Weidinger G. Clinical efficacy of naftifine. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. R. A. Fromtling. Prous, Barcelona 1987; 497–50915. Weidinger G. Clinical efficacy of naftifine. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. R. A. Fromtling. Prous, Barcelona 1987; 497–509
   Google Scholar